AI Portfolio Summary
In 2025 Q4, DIADEMA PARTNERS LP maintained a portfolio of 201 distinct positions. The most significant new addition to the portfolio was VERTEX PHARMACEUTICA, which now represents 6.90% of the total fund value. Conversely, DIADEMA PARTNERS LP completely exited their position in SPDR S&P 500 ETF TR.
Total Positions
201
Quarter
2025 Q4
Top Holding
VRTX (6.9%)
Top 10 Concentration
39.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 201
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VRTX
CALL
VERTEX PHARMACE...
|
CALL Option | 6.90% | — |
#1
Prev: #—
|
8.3 | 88,300 | no change |
NEW
|
88,300 | $40,031,688 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 5.25% | — |
#2
Prev: #—
|
7.1 | 250,000 | no change |
NEW
|
250,000 | $30,482,500 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PUT
PRAXIS PRECISIO...
|
PUT Option | 5.11% | 1.36% |
#3
22
Prev: #25
|
3.5 | 600 | 0.6% |
P
S
|
100,600 | $29,650,844 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
CALL
VIKING THERAPEU...
|
CALL Option | 4.17% | 2.72% |
#4
3
Prev: #7
|
5.2 | 283,800 | 70.1% |
P
S
|
688,900 | $24,235,502 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
CALL
AVIDITY BIOSCIE...
|
CALL Option | 4.08% | 2.23% |
#5
4
Prev: #9
|
5.1 | 127,900 | 63.9% |
P
S
|
328,000 | $23,658,640 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QQQ
PUT
INVESCO QQQ TR
|
PUT Option | 3.17% | — |
#6
Prev: #—
|
4.8 | 30,000 | no change |
NEW
|
30,000 | $18,429,300 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
CALL
JAZZ PHARMACEUT...
|
CALL Option | 3.08% | 3.37% |
#7
3
Prev: #4
|
3.2 | 5,300 | 5.3% |
P
S
|
105,300 | $17,901,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
CALL
APOGEE THERAPEU...
|
CALL Option | 2.74% | 1.29% |
#8
20
Prev: #28
|
4.1 | 83,700 | 65.7% |
P
S
|
211,100 | $15,933,828 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
PUT
BRIDGEBIO PHARM...
|
PUT Option | 2.64% | — |
#9
Prev: #—
|
4.6 | 200,000 | no change |
NEW
|
200,000 | $15,298,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Unknown | 2.41% | 0.62% |
#10
44
Prev: #54
|
3.0 | 22,721 | 7.0% |
P
S
|
345,880 | $13,973,552 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JNJ
JOHNSON & JOHNS...
|
Unknown | 2.37% | — |
#11
Prev: #—
|
4.4 | 66,444 | no change |
NEW
|
66,444 | $13,750,586 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
CALL
STRUCTURE THERA...
|
CALL Option | 2.30% | — |
#12
Prev: #—
|
4.4 | 191,700 | no change |
NEW
|
191,700 | $13,332,735 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
VIKING THERAPEU...
|
Unknown | 2.04% | 1.30% |
#13
14
Prev: #27
|
3.8 | 143,160 | 73.9% |
P
S
|
336,849 | $11,850,348 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
PUT
VIKING THERAPEU...
|
PUT Option | 1.92% | — |
#14
Prev: #—
|
4.3 | 316,700 | no change |
NEW
|
316,700 | $11,141,506 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
CALL
BRIDGEBIO PHARM...
|
CALL Option | 1.84% | 1.75% |
#15
1
Prev: #16
|
2.7 | 8,200 | 6.2% |
P
S
|
139,600 | $10,678,004 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JNJ
CALL
JOHNSON & JOHNS...
|
CALL Option | 1.78% | — |
#16
Prev: #—
|
4.2 | 50,000 | no change |
NEW
|
50,000 | $10,347,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Unknown | 1.76% | 0.90% |
#17
21
Prev: #38
|
3.7 | 34,024 | 81.7% |
P
S
|
75,644 | $10,200,972 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INCY
PUT
INCYTE CORP
|
PUT Option | 1.70% | — |
#18
Prev: #—
|
4.2 | 100,000 | no change |
NEW
|
100,000 | $9,877,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
CALL
INSMED INC
|
CALL Option | 1.58% | — |
#19
Prev: #—
|
4.1 | 52,800 | no change |
NEW
|
52,800 | $9,189,312 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CALL
CAPRICOR THERAP...
|
CALL Option | 1.55% | 0.55% |
#20
40
Prev: #60
|
1.1 | 12,300 | 4.1% |
P
S
|
312,300 | $9,012,978 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMRN
BIOMARIN PHARMA...
|
Unknown | 1.50% | 2.95% |
#21
15
Prev: #6
|
0.6 | -66,516 | -31.2% |
P
S
|
146,361 | $8,698,234 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
CALL
IONIS PHARMACEU...
|
CALL Option | 1.45% | 1.67% |
#22
3
Prev: #19
|
2.6 | 6,200 | 6.2% |
P
S
|
106,200 | $8,401,482 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REGN
REGENERON PHARM...
|
Unknown | 1.37% | 4.34% |
#23
21
Prev: #2
|
0.5 | -19,860 | -65.8% |
P
S
|
10,300 | $7,950,261 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INDV
CALL
INDIVIOR PLC
|
CALL Option | 1.36% | — |
#24
Prev: #—
|
4.0 | 220,300 | no change |
NEW
|
220,300 | $7,904,364 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
PUT
UNIQURE NV
|
PUT Option | 1.24% | 4.48% |
#25
24
Prev: #1
|
1.0 | 1,800 | 0.6% |
P
S
|
301,800 | $7,222,074 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPY
PUT
SPDR S&P 500 ET...
|
PUT Option | 0.00% | 3.41% |
Sold All 😨
(Was: #3) |
0.0 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
CALL
AGIOS PHARMACEU...
|
CALL Option | 0.00% | 2.28% |
Sold All 😨
(Was: #8) |
0.0 | -222,100 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INCY
CALL
INCYTE CORP
|
CALL Option | 0.00% | 2.17% |
Sold All 😨
(Was: #10) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMY
CALL
BRISTOL-MYERS S...
|
CALL Option | 0.00% | 2.08% |
Sold All 😨
(Was: #12) |
0.0 | -180,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
PUT
ELI LILLY & CO
|
PUT Option | 0.00% | 1.95% |
Sold All 😨
(Was: #14) |
0.0 | -10,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
PUT
SOLENO THERAPEU...
|
PUT Option | 0.00% | 1.73% |
Sold All 😨
(Was: #17) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
PUT
JAZZ PHARMACEUT...
|
PUT Option | 0.00% | 1.69% |
Sold All 😨
(Was: #18) |
0.0 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMY
BRISTOL-MYERS S...
|
Unknown | 0.00% | 1.50% |
Sold All 😨
(Was: #21) |
0.0 | -130,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Unknown | 0.00% | 1.36% |
Sold All 😨
(Was: #26) |
0.0 | -37,754 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Unknown | 0.00% | 1.09% |
Sold All 😨
(Was: #33) |
0.0 | -75,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRMY
CALL
HARMONY BIOSCIE...
|
CALL Option | 0.00% | 1.06% |
Sold All 😨
(Was: #34) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UPB
CALL
UPSTREAM BIO IN...
|
CALL Option | 0.00% | 0.96% |
Sold All 😨
(Was: #35) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
CALL
SCHOLAR ROCK HL...
|
CALL Option | 0.00% | 0.95% |
Sold All 😨
(Was: #36) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
PUT
ULTRAGENYX PHAR...
|
PUT Option | 0.00% | 0.95% |
Sold All 😨
(Was: #37) |
0.0 | -123,300 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Unknown | 0.00% | 0.78% |
Sold All 😨
(Was: #44) |
0.0 | -23,140 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
CALL
COGENT BIOSCIEN...
|
CALL Option | 0.00% | 0.73% |
Sold All 😨
(Was: #46) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
PUT
ARCTURUS THERAP...
|
PUT Option | 0.00% | 0.71% |
Sold All 😨
(Was: #47) |
0.0 | -150,900 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRNA
CALL
MODERNA INC
|
CALL Option | 0.00% | 0.67% |
Sold All 😨
(Was: #49) |
0.0 | -102,100 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SCPH
CALL
SCPHARMACEUTICA...
|
CALL Option | 0.00% | 0.67% |
Sold All 😨
(Was: #50) |
0.0 | -462,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 0.00% | 0.66% |
Sold All 😨
(Was: #51) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
REPL
CALL
REPLIMUNE GROUP...
|
CALL Option | 0.00% | 0.66% |
Sold All 😨
(Was: #52) |
0.0 | -612,300 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Unknown | 0.00% | 0.65% |
Sold All 😨
(Was: #53) |
0.0 | -64,250 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
ALKERMES PLC
|
Unknown | 0.00% | 0.55% |
Sold All 😨
(Was: #61) |
0.0 | -72,079 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
CALL
ACADIA PHARMACE...
|
CALL Option | 0.00% | 0.49% |
Sold All 😨
(Was: #62) |
0.0 | -89,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Unknown | 0.00% | 0.46% |
Sold All 😨
(Was: #63) |
0.0 | -120,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
CALL
MBX BIOSCIENCES...
|
CALL Option | 0.00% | 0.45% |
Sold All 😨
(Was: #65) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SMMT
CALL
SUMMIT THERAPEU...
|
CALL Option | 0.00% | 0.39% |
Sold All 😨
(Was: #70) |
0.0 | -74,700 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVAX
CALL
NOVAVAX INC
|
CALL Option | 0.00% | 0.38% |
Sold All 😨
(Was: #72) |
0.0 | -173,500 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVO
NOVO-NORDISK A ...
|
Unknown | 0.00% | 0.35% |
Sold All 😨
(Was: #74) |
0.0 | -25,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRMY
PUT
HARMONY BIOSCIE...
|
PUT Option | 0.00% | 0.35% |
Sold All 😨
(Was: #75) |
0.0 | -50,100 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Unknown | 0.00% | 0.35% |
Sold All 😨
(Was: #77) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Unknown | 0.00% | 0.33% |
Sold All 😨
(Was: #78) |
0.0 | -30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNMD
MIND MEDICINE M...
|
Unknown | 0.00% | 0.32% |
Sold All 😨
(Was: #79) |
0.0 | -105,891 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SKYE
CALL
SKYE BIOSCIENCE...
|
CALL Option | 0.00% | 0.30% |
Sold All 😨
(Was: #82) |
0.0 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SUPN
SUPERNUS PHARMA...
|
Unknown | 0.00% | 0.27% |
Sold All 😨
(Was: #85) |
0.0 | -22,348 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
CALL
AMICUS THERAPEU...
|
CALL Option | 0.00% | 0.26% |
Sold All 😨
(Was: #87) |
0.0 | -131,400 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CPRX
CATALYST PHARMA...
|
Unknown | 0.00% | 0.25% |
Sold All 😨
(Was: #88) |
0.0 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVPH
REVIVA PHARMACE...
|
Unknown | 0.00% | 0.24% |
Sold All 😨
(Was: #89) |
0.0 | -2,506,921 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
ARCTURUS THERAP...
|
Unknown | 0.00% | 0.23% |
Sold All 😨
(Was: #90) |
0.0 | -48,811 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Unknown | 0.00% | 0.15% |
Sold All 😨
(Was: #96) |
0.0 | -185,286 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MRNA
MODERNA INC
|
Unknown | 0.00% | 0.13% |
Sold All 😨
(Was: #97) |
0.0 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNYA
TENAYA THERAPEU...
|
Unknown | 0.00% | 0.13% |
Sold All 😨
(Was: #99) |
0.0 | -315,519 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
ALECTOR INC
|
Unknown | 0.00% | 0.10% |
Sold All 😨
(Was: #102) |
0.0 | -136,023 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Unknown | 0.00% | 0.09% |
Sold All 😨
(Was: #106) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CCCC
CALL
C4 THERAPEUTICS...
|
CALL Option | 0.00% | 0.08% |
Sold All 😨
(Was: #107) |
0.0 | -140,700 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Unknown | 0.00% | 0.07% |
Sold All 😨
(Was: #109) |
0.0 | -9,189 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLYM
CLIMB BIO INC
|
Unknown | 0.00% | 0.07% |
Sold All 😨
(Was: #110) |
0.0 | -136,488 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OVID
OVID THERAPEUTI...
|
Unknown | 0.00% | 0.06% |
Sold All 😨
(Was: #113) |
0.0 | -187,739 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Unknown | 0.00% | 0.06% |
Sold All 😨
(Was: #114) |
0.0 | -43,616 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RCEL
CALL
AVITA MEDICAL I...
|
CALL Option | 0.00% | 0.03% |
Sold All 😨
(Was: #118) |
0.0 | -25,100 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
ANAPTYSBIO INC
|
Unknown | 0.00% | 0.03% |
Sold All 😨
(Was: #119) |
0.0 | -3,295 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVRD
TVARDI THERAPEU...
|
Unknown | 0.00% | 0.02% |
Sold All 😨
(Was: #121) |
0.0 | -2,185 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MREO
PUT
MEREO BIOPHARMA...
|
PUT Option | 0.00% | 0.02% |
Sold All 😨
(Was: #122) |
0.0 | -39,400 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
PUT
KODIAK SCIENCES...
|
PUT Option | 0.00% | 0.00% |
Sold All 😨
(Was: #125) |
0.0 | -1,100 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PMVP
PMV PHARMACEUTI...
|
Unknown | 0.00% | 0.00% |
Sold All 😨
(Was: #126) |
0.0 | -11,300 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AUPH
PUT
AURINIA PHARMAC...
|
PUT Option | 0.00% | 0.00% |
Sold All 😨
(Was: #128) |
0.0 | -700 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 201 holdings